M&R Capital Management’s Idexx Laboratories IDXX Stock Holding History

M&R Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4	Closed	–	–	563
2016 Q4	$0	Hold	4	–	–	﹤0.01%	564
2016 Q3	$0	Buy	+4	New	+$422	﹤0.01%	551

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

M&R Capital Management's IDXX Position: Q1 2017 in Review

M&R Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2017, closing a stake of 4 shares.

M&R Capital Management first reported a position in IDXX in Q3 2016 and held it in 2 quarters. The position peaked at $0 in Q4 2016. 542 funds tracked by Wall St. Rank hold IDXX as of Q1 2017.

M&R Capital Management reported no remaining Idexx Laboratories position as of Q1 2017 after selling out during the quarter.
M&R Capital Management sold 4 Idexx Laboratories shares in Q1 2017.
M&R Capital Management first reported a position in Idexx Laboratories in Q3 2016 and held it in 2 quarters.
M&R Capital Management's Idexx Laboratories position peaked at $0 in Q4 2016.
542 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2017.

Based on M&R Capital Management's 13F filing for Q1 2017, filed 15 May 2017.